Cargando…

Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype

Targeted proteasomal and autophagic protein degradation, often employing bifunctional modalities, is a new paradigm for modulation of protein function. In an attempt to explore protein degradation by means of autophagy we combine arylidene-indolinones reported to bind the autophagy-related LC3B-prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Gang, Xie, Jianing, Hinterndorfer, Matthias, Cigler, Marko, Dötsch, Lara, Imrichova, Hana, Lampe, Philipp, Cheng, Xiufen, Adariani, Soheila Rezaei, Winter, Georg E., Waldmann, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689823/
https://www.ncbi.nlm.nih.gov/pubmed/38036533
http://dx.doi.org/10.1038/s41467-023-43657-6
_version_ 1785152430235713536
author Xue, Gang
Xie, Jianing
Hinterndorfer, Matthias
Cigler, Marko
Dötsch, Lara
Imrichova, Hana
Lampe, Philipp
Cheng, Xiufen
Adariani, Soheila Rezaei
Winter, Georg E.
Waldmann, Herbert
author_facet Xue, Gang
Xie, Jianing
Hinterndorfer, Matthias
Cigler, Marko
Dötsch, Lara
Imrichova, Hana
Lampe, Philipp
Cheng, Xiufen
Adariani, Soheila Rezaei
Winter, Georg E.
Waldmann, Herbert
author_sort Xue, Gang
collection PubMed
description Targeted proteasomal and autophagic protein degradation, often employing bifunctional modalities, is a new paradigm for modulation of protein function. In an attempt to explore protein degradation by means of autophagy we combine arylidene-indolinones reported to bind the autophagy-related LC3B-protein and ligands of the PDEδ lipoprotein chaperone, the BRD2/3/4-bromodomain containing proteins and the BTK- and BLK kinases. Unexpectedly, the resulting bifunctional degraders do not induce protein degradation by means of macroautophagy, but instead direct their targets to the ubiquitin-proteasome system. Target and mechanism identification reveal that the arylidene-indolinones covalently bind DCAF11, a substrate receptor in the CUL4A/B-RBX1-DDB1-DCAF11 E3 ligase. The tempered α, β-unsaturated indolinone electrophiles define a drug-like DCAF11-ligand class that enables exploration of this E3 ligase in chemical biology and medicinal chemistry programs. The arylidene-indolinone scaffold frequently occurs in natural products which raises the question whether E3 ligand classes can be found more widely among natural products and related compounds.
format Online
Article
Text
id pubmed-10689823
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106898232023-12-02 Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype Xue, Gang Xie, Jianing Hinterndorfer, Matthias Cigler, Marko Dötsch, Lara Imrichova, Hana Lampe, Philipp Cheng, Xiufen Adariani, Soheila Rezaei Winter, Georg E. Waldmann, Herbert Nat Commun Article Targeted proteasomal and autophagic protein degradation, often employing bifunctional modalities, is a new paradigm for modulation of protein function. In an attempt to explore protein degradation by means of autophagy we combine arylidene-indolinones reported to bind the autophagy-related LC3B-protein and ligands of the PDEδ lipoprotein chaperone, the BRD2/3/4-bromodomain containing proteins and the BTK- and BLK kinases. Unexpectedly, the resulting bifunctional degraders do not induce protein degradation by means of macroautophagy, but instead direct their targets to the ubiquitin-proteasome system. Target and mechanism identification reveal that the arylidene-indolinones covalently bind DCAF11, a substrate receptor in the CUL4A/B-RBX1-DDB1-DCAF11 E3 ligase. The tempered α, β-unsaturated indolinone electrophiles define a drug-like DCAF11-ligand class that enables exploration of this E3 ligase in chemical biology and medicinal chemistry programs. The arylidene-indolinone scaffold frequently occurs in natural products which raises the question whether E3 ligand classes can be found more widely among natural products and related compounds. Nature Publishing Group UK 2023-11-30 /pmc/articles/PMC10689823/ /pubmed/38036533 http://dx.doi.org/10.1038/s41467-023-43657-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Xue, Gang
Xie, Jianing
Hinterndorfer, Matthias
Cigler, Marko
Dötsch, Lara
Imrichova, Hana
Lampe, Philipp
Cheng, Xiufen
Adariani, Soheila Rezaei
Winter, Georg E.
Waldmann, Herbert
Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype
title Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype
title_full Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype
title_fullStr Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype
title_full_unstemmed Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype
title_short Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype
title_sort discovery of a drug-like, natural product-inspired dcaf11 ligand chemotype
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689823/
https://www.ncbi.nlm.nih.gov/pubmed/38036533
http://dx.doi.org/10.1038/s41467-023-43657-6
work_keys_str_mv AT xuegang discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT xiejianing discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT hinterndorfermatthias discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT ciglermarko discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT dotschlara discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT imrichovahana discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT lampephilipp discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT chengxiufen discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT adarianisoheilarezaei discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT wintergeorge discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype
AT waldmannherbert discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype